| PEROXIREDOXIN1 IS A THERAPEUTIC TARGET IN GROUP-3 MEDULLOBLASTOMA | |
Babu, Sajesh1; Omar, Refaat1; Fediuk, Holly1; Li, Lin1; Coudiere-Morrision, Ludivine2; Wang, W.3 ; Pu, J.3; Sun, H. D.3; Werbowetski-Ogilvie, Tamra4; Woelfl, Matthias5; Remke, Marc6; Taylor, Michael7; Eberhart, Charles8; Symons, Marc9; Ruggieri, Rosamaria10; Vanan, Magimairajan Issai11
| |
| 2017-11-01 | |
| 发表期刊 | NEURO-ONCOLOGY
 |
| ISSN | 1522-8517 |
| 卷号 | 19页码:200-200 |
| 语种 | 英语 |
| WOS记录号 | WOS:000415152503173 |
| 引用统计 | |
| 文献类型 | 期刊论文 |
| 条目标识符 | http://ir.kib.ac.cn/handle/151853/60630 |
| 专题 | 植物化学与西部植物资源持续利用国家重点实验室 |
| 作者单位 | 1.Canc Care Manitoba, Winnipeg, MB, Canada 2.Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada 3.Kunming Inst Bot, Kunming, Yunnan, Peoples R China 4.Univ Manitoba, Regenerat Med Program, Winnipeg, MB, Canada 5.Univ Wurzburg, Univ Childrens Hosp, Pediat Hematol & Oncol, Wurzburg, Germany 6.Deutsch Krebsforschungszentrum DKFZ, Dusseldorf, Germany 7.Hosp Sick Children, Div Neurosurg, Toronto, ON, Canada 8.Johns Hopkins Univ, Div Pediat Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA 9.Feinstein Inst Med Res, Manhasset, NY USA 10.Mayo Clin, Phoenix, AZ USA 11.CancerCare Manitoba CCMB, Div Pediat Hematol Oncol & BMT, Pediat Neurooncol, Winnipeg, MB, Canada |
| 推荐引用方式 GB/T 7714 | Babu, Sajesh,Omar, Refaat,Fediuk, Holly,et al. PEROXIREDOXIN1 IS A THERAPEUTIC TARGET IN GROUP-3 MEDULLOBLASTOMA[J]. NEURO-ONCOLOGY,2017,19:200-200. |
| APA | Babu, Sajesh.,Omar, Refaat.,Fediuk, Holly.,Li, Lin.,Coudiere-Morrision, Ludivine.,...&Vanan, Magimairajan Issai.(2017).PEROXIREDOXIN1 IS A THERAPEUTIC TARGET IN GROUP-3 MEDULLOBLASTOMA.NEURO-ONCOLOGY,19,200-200. |
| MLA | Babu, Sajesh,et al."PEROXIREDOXIN1 IS A THERAPEUTIC TARGET IN GROUP-3 MEDULLOBLASTOMA".NEURO-ONCOLOGY 19(2017):200-200. |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论